Paper Details
- Home
- Paper Details
Original Abstract of the Article :
OBJECTIVE: To compare the long-term antihypertensive efficacy, tolerability, and metabolic effects of prazosin GITS and enalapril. DESIGN: Randomized, controlled, multicenter study of 26 weeks duration. SETTING: Office practices of 20 physicians in Mumbai, India. PATIENTS: Males and females, aged...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/11233387
データ提供:米国国立医学図書館(NLM)
Comparing Antihypertensive Medications: Prazosin GITS vs Enalapril
The management of hypertension, particularly in patients with diabetes mellitus, is a crucial aspect of cardiovascular health. This study compares the long-term efficacy, tolerability, and metabolic effects of two antihypertensive medications, prazosin GITS and enalapril, in hypertensive patients with diabetes mellitus. The researchers conducted a randomized, controlled, multicenter study to assess the effectiveness and safety of these medications in this specific patient population.Prazosin GITS Shows Promise for Hypertensive Patients with Diabetes
The study reveals that prazosin GITS, a long-acting form of prazosin, demonstrates comparable antihypertensive efficacy to enalapril. This finding holds significant implications for clinicians treating hypertensive patients with diabetes, offering a valuable alternative treatment option. It's like discovering a new oasis in the desert of hypertension, providing a refreshing source of relief and potential for improved cardiovascular health.Navigating the Desert of Cardiovascular Health
The study underscores the importance of considering the metabolic effects of antihypertensive medications, particularly in patients with diabetes. It's like navigating the desert of cardiovascular health, where attention must be paid to the delicate balance of different factors. Prazosin GITS, in this study, demonstrated a favorable effect on certain lipid fractions, potentially contributing to better overall metabolic control. This research highlights the need for clinicians to carefully weigh the risks and benefits of different medications to optimize treatment outcomes for their patients.Dr.Camel's Conclusion
This research provides valuable insights into the long-term efficacy and metabolic effects of prazosin GITS compared to enalapril in hypertensive patients with diabetes mellitus. The findings suggest that prazosin GITS represents a promising alternative for managing hypertension in this specific patient population. It’s like discovering a new path in the desert of cardiovascular health, offering a more effective and well-tolerated approach for achieving and maintaining healthy blood pressure levels.Date :
- Date Completed 2001-05-03
- Date Revised 2013-11-21
Related Literature
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.